ACT8 - Bureau Circular No. 08 S. 2001
ACT8 - Bureau Circular No. 08 S. 2001
ACT8 - Bureau Circular No. 08 S. 2001
DEPARTMENT OF HEALTH
BUREAU OF FOOD AND DRUGS
Civic Drive, Filinvest Corporate City
Alabang, Muntinlupa City
July 6, 2001
BUREAU CIRCULAR
No. __8___ s. 2001
Chapter II of R.A. 3720 as amended by E.O.175, otherwise known as the "Foods, Drugs, Devices and
Cosmetics Act" declares it the policy of the state, "to insure safe and good quality supply of food, drug and
cosmetics and to regulate the production, sale and traffic of the same to protect the health of the people".
For the proper implementation of the above policy and in accordance with Chapter II, Section 3 (b) of this
same Act and Section 12.1 of A.O.43-A, s. 1999 with subject "Current Good Manufacturing Practice
Guidelines for Drugs", the following guidelines to be observed on the recall of all types of regulated products
from the market are hereby promulgated.
1. General Information
Recalls are actions taken to remove a product from the market. Recalls maybe initiated by BFAD or are
voluntary actions on the part of manufacturers and distributors to carry out their responsibility to protect
the public health and well-being from products that present a risk of injury or gross deception or are
otherwise deceptive.
Recalls are an appropriate alternative method for removing or correcting marketed products, including
their labeling and/or promotional literature, that violate the laws administered by the Bureau of Food
and Drugs (BFAD). They are generally more efficient and afford equal and more timely consumer
protection than formal administrative or civil actions, especially when the product has been widely
distributed.
2. Scope
This Guidelines shall apply to the recall of all types of products regulated by the Bureau of Food and
Drugs.
A BFAD Committee for Product Recall is hereby created to evaluate the health risks presented by a
violative product. It shall be composed of the following members:
• Chief of Product Services Division (PSD), Laboratory Services Division (LSD) and Legal
Information and Compliance Division (LICD)
• Chief of Regulation Division I (RD I) or Chief of Regulation Division II (RD II)
• Medical Consultant / Deputy Director
In case a product recall is agreed upon, a written concurrence shall be submitted to the BFAD Director
for approval and proper issuance of recall order.
An evaluation of the health hazard presented by a product being recalled or considered for recall will be
conducted by the BFAD Committee for Product Recall and will take into account, but not be limited to,
the following factors:
4.1. Whether any disease or injury has already occurred from the use of the violative product.
4.2. Whether any existing condition(s) could contribute to a clinical situation that could expose humans
or animals to a health hazard. Any conclusion shall be supported as completely as possible by
scientific documentation and/or statements that the conclusion is the opinion of the individual(s)
making the health hazard determination.
4.3. Assessment of hazard to various segments of the population, e.g. pregnant women, children,
surgical patients, pets, livestock, etc. who are expected to be exposed to the product being
considered. Particular attention should be given to the hazard to those individuals or groups who
may be at greater risk.
4.4. Assessment of the degree of seriousness of the health hazard to which the population at risk would
be exposed.
A product will also be considered for recall if it presents a risk of gross deception to the general
public.
5. Recall Classification
5.1. Class I Recall – is a situation in which there is a reasonable probability that the use or exposure to
a violative product will cause serious adverse health consequences or death.
5.2. Class II Recall – is a situation in which use or exposure to a violative product may cause temporary
or medically reversible adverse health consequences or where the probability of serious adverse
health consequences is remote.
5.3. Class III Recall – is a situation in which the use or exposure to a violative product is not likely to
cause adverse health consequences.
Some examples of product defects that are subject to recall are listed according to classification in
Appendix 1.
6. Who Will Initiate Recall
Recalls may be undertaken by the manufacturers and distributors of a violative product 1) at any
time on their own initiative or 2) in response to a recall order by BFAD.
A firm may decide of its own volition and under any circumstances to remove or correct a
distributed product. A firm that does so because it believes the product to be violative (i.e., the
product presents a risk of injury or does not conform to registered specifications) is mandated to
notify immediately the BFAD.
6.1.2 Reason for the removal or correction and the date and circumstances under which the
product deficiency or possible deficiency was discovered.
6.1.3 Evaluation of the risk associated with the deficiency or possible deficiency
6.1.4 Total amount of such products produced and/or the time span of the production
6.1.6 Distribution information, including the number of distribution outlets and where necessary, the
names and addresses of the distribution outlets
6.1.7 A copy of the firm’s recall communication if any has been issued or a proposed
communication if none has been issued yet.
6.1.9 Name and telephone number of the official who should be contacted concerning the recall
The Director of the BFAD may order a firm to initiate a recall upon the recommendation of the
BFAD Committee for Product Recall when the following determinations have been made:
6.2.1. That a product that has been distributed presents a risk of illness or injury or gross
consumer deception
6.2.2. That the firm has not initiated a recall of the product
6.2.3. That an agency action is necessary or advisable to protect the public health and welfare
The firm shall be notified of decision to order recall, and of the need to begin immediately a recall
of the product. The notification will specify the violation, the health hazard classification, the
recommended recall strategy to be undertaken by the firm and any other instructions appropriate to
the conduct of the recall.
7. General Procedure for Product Recall
7.1 The BFAD Committee for Product Recall, upon receipt of a case report, will assess the hazard
presented by a product being recalled or considered for recall. Such case report may come from
the responsible company (company initiated), BFAD technical divisions, DOH or other
government offices, or consumer complaints.
7.2 The Committee will submit a written recommendation to the BFAD Director for the issuance of a
recall order or to confirm a company initiated recall
7.3 The concerned DOH Offices will be informed of the decision to order product recall
7.4. A Public Health Alert will be issued within twenty-four (24) hours for cases that have been
determined as Class I or Class II Recall.
7.5 If recall is not firm-initiated, a notification will be issued to the firm regarding the recall
recommendation together with a request for the submission of recall plan/procedure and other
information listed in section 6.2.
7.6. An in-depth inspection of responsible establishment/ production facilities where the violation
occurred will be conducted by the concerned inspection division of the BFAD (RD I or RD II)
7.7 If necessary, other DOH units and government agencies will be utilized in implementing the recall
7.8 The concerned BFAD inspection division will audit the recall operation by developing and
implementing a recall audit program.
7.9. In case the concerned firm refuses to conduct a product recall, regulatory action and/or other
measures will be pursued by BFAD
7.10. The BFAD will determine when a recall will be terminated and upon such determination, provide
written notification of the termination to the recalling firm.
Within twenty-four (24) hours after the BFAD Director issues an Order for Product Recall, the
BFAD will issue Public Health Alert for the purpose of alerting concerned populations to either
serious health hazards or other situations deemed to be in the public interest.
Class I Recall - Notices and warnings shall be issued, by tri-media, to the general public, health
professionals, health institutions, industry associations, distribution outlets for such products and all
other concerned parties.
Class II Recall – Notices and warnings shall be issued to 1) groups and institutions that are
identified as those who generally use or are exposed to the product and 2) those who could help
remove such violative products from the market or prevent such products from being used
Class III Recall - Notices and warnings shall be issued to concerned parties and distribution
outlets.
9. Recall Strategy
A recall strategy suitable for individual recall circumstances shall be developed by the BFAD and/or the
recalling firm. The following elements shall be included in a recall strategy:
9.1 Depth of Recall – depending on the product’s degree of hazard and extent of distribution, the recall
strategy will specify the level in the distribution chain which the recall is to extend. Ex. consumer
level, retail level or wholesale level
9.2 Public Alert /Warning to be issued by the recalling firm – the purpose is to alert the public that a
product being recalled presents a serious hazard to health
9.3 Effectiveness checks – the purpose is to verify that all consignees at the recall depth specified by
the strategy have received notification about the recall and have taken appropriate action.
In developing a recall strategy the duration to complete the recall operation should also be considered.
Completion of a recall operation should be within the following recommended period:
Class I Recall - seven (7) days
Class II Recall - fifteen (15) days
Class III Recall - thirty (30) days
10.1. The recalling firm is mandated to submit periodic recall status reports to the BFAD so that the agency
may assess the progress of the recall. The frequency of such reports will be determined by the
relative urgency of the recall and will be specified by the BFAD in each recall case; generally the
reporting interval will be between 2 and 4 weeks.
10.2. Unless otherwise specified, the recall status report should contain the following information:
10.2.1 Number of consignees notified of the recall, and date and method of notification
10.2.2 Number of consignees responding to the recall communication and quantity of products on
hand at the time it was received
10.2.3 Number of consignees that did not respond (if needed, the identity of non-responding
consignees may be requested by the BFAD)
10.2.4 Number of products returned or corrected by each consignee contacted and the quantity of
products accounted for
10.3 Recall status reports are to be discontinued when the recall is terminated by BFAD
11. Refusal By or Failure of Firm to Conduct Effective Product Recall
Seizure, multiple seizure or other court action shall be undertaken by the BFAD when a firm refuses to
conduct a recall ordered by BFAD, or where the agency has reason to believe that a recall would not be
effective, determines that a recall is ineffective, or discovers that a violation is continuing.
Products which have been subject of a recall must immediately be removed from the market and must not
be allowed for distribution and sale. Upon completion of the recall procedure, the concerned company shall
notify the BFAD of the final disposition of the product.